Association of Different Obesity Phenotypes with Sarcopenia in Han Chinese Middle-Aged and Elderly with Type 2 Diabetes Individuals

por Lu, Lanyu, Liu, Bowei, Ma, Yongfang
Publicado 2023

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells

por Li, Amin, Cao, Weiya, Liu, Xueke, Zhang, Yinci, Ma, Yongfang, Xu, Ruyue, Tang, Xiaolong
Publicado 2020

IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

por Cai, Wenpeng, Ma, Yongfang, Song, Li, Cao, Niandie, Gao, Jiafeng, Zhou, Shuping, Tang, Xiaolong
Publicado 2023

Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer

por Zhu, Ying, Pu, Qiang, Zhang, Qiongyin, Liu, Yang, Ma, Yongfang, Yuan, Yue, Liu, Lunxu, Zhu, Wen
Publicado 2023

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway

por Xu, Ruyue, Zhang, Yinci, Li, Amin, Ma, Yongfang, Cai, Wenpeng, Song, Li, Xie, Yinghai, Zhou, Shuping, Cao, Weiya, Tang, Xiaolong
Publicado 2021

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

por Ma, Yongfang, Xu, Ruyue, Liu, Xueke, Zhang, Yinci, Song, Li, Cai, Shuyu, Zhou, Shuping, Xie, Yinghai, Li, Amin, Cao, Weiya, Tang, Xiaolong
Publicado 2021

BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy

por Cao, Weiya, Liu, Xueke, Zhang, Yinci, Li, Amin, Xie, Yinghai, Zhou, Shuping, Song, Li, Xu, Ruyue, Ma, Yongfang, Cai, Shiyu, Tang, Xiaolong
Publicado 2021

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells

por Li, Amin, Cao, Weiya, Liu, Xueke, Zhang, Yinci, Ma, Yongfang, Xu, Ruyue, Zhang, Rongbo, Liu, Xinkuang, Zhou, Shuping, Wang, Ruikai, Liu, Jiachang, Tang, Xiaolong
Publicado 2020

miR-410 induces both epithelial–mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer

por Yuan, Yue, Liao, Hu, Pu, Qiang, Ke, Xixian, Hu, Xueting, Ma, Yongfang, Luo, Xinmei, Jiang, Qianqian, Gong, Yi, Wu, Min, Liu, Lunxu, Zhu, Wen
Publicado 2020

hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway

por Shen, Jing, Cai, Wenpeng, Ma, Yongfang, Xu, Ruyue, Huo, Zhen, Song, Li, Qiu, Xinyin, Zhang, Yinci, Li, Amin, Cao, Weiya, Zhou, Shuping, Tang, Xiaolong
Publicado 2020

RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway

por Tang, Xiaolong, Li, Amin, Xie, Chunmei, Zhang, Yinci, Liu, Xueke, Xie, Yinghai, Wu, Binquan, Zhou, Shuping, Huang, Xudong, Ma, Yongfang, Cao, Weiya, Xu, Ruyue, Shen, Jing, Huo, Zhen, Cai, Shuyu, Liang, Yong, Ma, Dong
Publicado 2020

Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway

por Tang, Xiaolong, Li, Amin, Xie, Chunmei, Zhang, Yinci, Liu, Xueke, Xie, Yinghai, Wu, Binquan, Zhou, Shuping, Huang, Xudong, Ma, Yongfang, Cao, Weiya, Xu, Ruyue, Shen, Jing, Huo, Zhen, Cai, Shuyu, Liang, Yong, Ma, Dong
Publicado 2021